Douglas W. Shevlin
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 1
-
- Cancer-related Molecular Pathways 5
- Pancreatic and Hepatic Oncology Research 2
-
- Thyroid Cancer Diagnosis and Treatment 5
-
- Cancer Genomics and Diagnostics 2
-
- Genetic factors in colorectal cancer 3
-
- BRCA gene mutations in cancer 2
-
- Intestinal and Peritoneal Adhesions 1
- Co-authors
- Paul J. GoodfellowSamuel A. WellsWilliam S. TungDetlef K. BartschZahid KaleemO. KiskerJeffrey A. NortonDonald R. Graham
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)American Journal of Clinical Pathology (1 paper)Genes Chromosomes and Cancer (3 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Douglas W. Shevlin
9 papers receiving 323 citations
Peers
Comparison fields: 5 of 53
- Clinical Biochemistry 94
- Applied Microbiology and Biotechnology 15
- Oncology 145
- Endocrinology, Diabetes and Metabolism 73
- Cancer Research 62
Countries citing papers authored by Douglas W. Shevlin
This map shows the geographic impact of Douglas W. Shevlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Shevlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Shevlin more than expected).
Fields of papers citing papers by Douglas W. Shevlin
This network shows the impact of papers produced by Douglas W. Shevlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Shevlin. The network helps show where Douglas W. Shevlin may publish in the future.
Co-authorship network
The 14 scholars most cited alongside Douglas W. Shevlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 105 | |
| 2 | 1997 | 10 | |
| 3 | 1997 | 4 | |
| 4 | 1997 | 38 | |
| 5 | Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss. | 1997 | 53 |
| 6 | 1996 | 30 | |
| 7 | 1996 | 19 | |
| 8 | 1996 | 2 | |
| 9 | 1995 | 68 |
About Douglas W. Shevlin
Douglas W. Shevlin is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pathology and Forensic Medicine, having authored 9 papers that have together received 329 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Genetic factors in colorectal cancer (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Genomics and Diagnostics (2 papers), BRCA gene mutations in cancer (2 papers), Bacterial Identification and Susceptibility Testing (1 paper) and Intestinal and Peritoneal Adhesions (1 paper). The work is most often cited by research in Clinical Biochemistry (94 citations), Applied Microbiology and Biotechnology (15 citations) and Oncology (145 citations). Douglas W. Shevlin has collaborated with scholars based in United States and Germany. Frequent co-authors include Paul J. Goodfellow, Samuel A. Wells, William S. Tung, Detlef K. Bartsch, Zahid Kaleem, O. Kisker, Jeffrey A. Norton, Donald R. Graham, Cheryl Drake and Charles D. Callahan. Their work appears in journals such as JNCI Journal of the National Cancer Institute, American Journal of Clinical Pathology and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.